Hispolon
Based on 1 Customer Validation
Hispolon, a polyphenol, can be isolated from Phellinus linteus. Hispolon possesses anticancer, antidiabetic, antioxidant, antiviral, hepatoprotective, anti-diabetic, and anti-inflammatory activities.
For research use only. We do not sell to patients.
- Purity: 99.42%
- CAS No.: 173933-40-9
- Formula: C12H12O4
- Molecular Weight:220.22
-
Storage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
All Antibiotic Isoforms
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A10 | IC50 |
37.05 μg/mL
Compound: 1
|
Antiproliferative activity against rat A10 cells after 24 hrs by MTT assay
Antiproliferative activity against rat A10 cells after 24 hrs by MTT assay
|
[PMID: 22967007] |
| A549 | IC50 |
0.183 μM
Compound: 8
|
Cytotoxicity against human A549 cells after 96 hrs by MTT assay
Cytotoxicity against human A549 cells after 96 hrs by MTT assay
|
[PMID: 15165144] |
| Bel-7402 | IC50 |
0.038 μM
Compound: 8
|
Cytotoxicity against human Bel7402 cells after 96 hrs by MTT assay
Cytotoxicity against human Bel7402 cells after 96 hrs by MTT assay
|
[PMID: 15165144] |
| BGC-823 | IC50 |
0.205 μM
Compound: 8
|
Cytotoxicity against human BGC823 cells after 96 hrs by MTT assay
Cytotoxicity against human BGC823 cells after 96 hrs by MTT assay
|
[PMID: 15165144] |
| DU-145 | IC50 |
28.6 μM
Compound: VA-1
|
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
|
[PMID: 25842364] |
| HCT-116 | IC50 |
5.2 μM
Compound: VA-1
|
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 25842364] |
| HCT-8 | IC50 |
0.199 μM
Compound: 8
|
Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
|
[PMID: 15165144] |
| HEK293 | IC50 |
7.3 μM
Compound: VA-1
|
Cytotoxicity against HEK293 cells expressing pcDNA3.1 after 72 hrs by MTT assay
Cytotoxicity against HEK293 cells expressing pcDNA3.1 after 72 hrs by MTT assay
|
[PMID: 25842364] |
| HEK293 | IC50 |
9.6 μM
Compound: VA-1
|
Cytotoxicity against HEK293 cells expressing ABCB1 after 72 hrs by MTT assay
Cytotoxicity against HEK293 cells expressing ABCB1 after 72 hrs by MTT assay
|
[PMID: 25842364] |
| KETR3 | IC50 |
0.206 μM
Compound: 8
|
Cytotoxicity against human Ketr3 cells after 96 hrs by MTT assay
Cytotoxicity against human Ketr3 cells after 96 hrs by MTT assay
|
[PMID: 15165144] |
| MCF7 | IC50 |
0.025 μM
Compound: 8
|
Cytotoxicity against human MCF7 cells after 96 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 96 hrs by MTT assay
|
[PMID: 15165144] |
| MCF7 | IC50 |
7.9 μM
Compound: VA-1
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 25842364] |
| MDA-MB-231 | IC50 |
32.2 μM
Compound: VA-1
|
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
|
[PMID: 25842364] |
| MDCK | IC50 |
36.2 μM
Compound: VA-1
|
Cytotoxicity against MDCK cells after 72 hrs by MTT assay
Cytotoxicity against MDCK cells after 72 hrs by MTT assay
|
[PMID: 25842364] |
| NIH3T3 | IC50 |
51.2 μM
Compound: VA-1
|
Cytotoxicity against mouse NIH/3T3 cells after 72 hrs by MTT assay
Cytotoxicity against mouse NIH/3T3 cells after 72 hrs by MTT assay
|
[PMID: 25842364] |
| PC-3 | IC50 |
12.9 μM
Compound: VA-1
|
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 25842364] |
| S1 | IC50 |
8.4 μM
Compound: VA-1
|
Cytotoxicity against human S1 cells after 72 hrs by MTT assay
Cytotoxicity against human S1 cells after 72 hrs by MTT assay
|
[PMID: 25842364] |
Hispolon (25 and 50 μM, 24-72 h) inhibits cell viability of U87MG cells[2].
Hispolon (25 and 50 μM, 24, 48 h) induces G2/M cell cycle arrest and apoptosis in U87MG cells[2].
Hispolon (25 and 50 μM, 2-8 h) decreases the expression of G1–S transition-related protein cyclin D4 but increases the expression of CDK inhibitor p21[2].
Hispolon (25 and 50 μM, 24 h) inhibits the migration of U87MG cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:U87MG cells
-
Concentration:25 and 50 μM
-
Incubation Time:24, 48, 72 h
-
Result:Inhibited cell viability in a dose and time dependent way.
-
Cell Line:U87MG cells
-
Concentration:25 and 50 μM
-
Incubation Time:2, 4, 8 h
-
Result:Decreased cyclin D4 level, and increased p21 level.
Hispolon (5 and 10 mg/kg, s.c.) reduces tumor growth in DBTRG xenograft mice[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:LPS-induced acute lung injury mice[3]
-
Dosage:2.5, 5 and 10 mg/kg
-
Administration:Intraperitoneal injection (i.p.)
-
Result:Alleviated the pathological effects in the LPS-challenged mouse.
Reduced the W/D ratio in the lung and MPO activity.
Decreased pro-Inflammatory cytokine production.
-
Animal Model:DBTRG xenograft mice[4]
-
Dosage:5 and 10 mg/kg
-
Administration:Subcutaneous injection (s.c.)
-
Result:Reduced tumor volume (RTV).
Inhibited GBM cell proliferation in vivo upon HE and ki-67 staining.
Chemical Information
-
CAS No. 173933-40-9
-
Appearance Solid
-
Molecular Weight 220.22
-
Formula C12H12O4
-
Color Light yellow to yellow
-
SMILES
CC(/C=C(O)/C=C/C1=CC(O)=C(C=C1)O)=O
-
Structure Classification
-
Initial Source
Phellinus linteus
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvent & Solubility
DMSO : 100 mg/mL (454.09 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (11.35 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (11.35 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[2]. Arcella A, et al. Effects of hispolon on glioblastoma cell growth. Environ Toxicol. 2017 Sep;32(9):2113-2123. [Content Brief]
[3]. Huang CY, et al. Attenuation of Lipopolysaccharide-Induced Acute Lung Injury by Hispolon in Mice, Through Regulating the TLR4/PI3K/Akt/mTOR and Keap1/Nrf2/HO-1 Pathways, and Suppressing Oxidative Stress-Mediated ER Stress-Induced Apoptosis and Autophagy. Nutrients. 2020 Jun 10;12(6):1742. [Content Brief]
[4]. Liao KF, et al. Hispolon Induces Apoptosis, Suppresses Migration and Invasion of Glioblastoma Cells and Inhibits GBM Xenograft Tumor Growth In Vivo. Molecules. 2021 Jul 26;26(15):4497. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 4.5409 mL | 22.7046 mL | 45.4091 mL | 113.5228 mL |
| 5 mM | 0.9082 mL | 4.5409 mL | 9.0818 mL | 22.7046 mL | |
| 10 mM | 0.4541 mL | 2.2705 mL | 4.5409 mL | 11.3523 mL | |
| 15 mM | 0.3027 mL | 1.5136 mL | 3.0273 mL | 7.5682 mL | |
| 20 mM | 0.2270 mL | 1.1352 mL | 2.2705 mL | 5.6761 mL | |
| 25 mM | 0.1816 mL | 0.9082 mL | 1.8164 mL | 4.5409 mL | |
| 30 mM | 0.1514 mL | 0.7568 mL | 1.5136 mL | 3.7841 mL | |
| 40 mM | 0.1135 mL | 0.5676 mL | 1.1352 mL | 2.8381 mL | |
| 50 mM | 0.0908 mL | 0.4541 mL | 0.9082 mL | 2.2705 mL | |
| 60 mM | 0.0757 mL | 0.3784 mL | 0.7568 mL | 1.8920 mL | |
| 80 mM | 0.0568 mL | 0.2838 mL | 0.5676 mL | 1.4190 mL | |
| 100 mM | 0.0454 mL | 0.2270 mL | 0.4541 mL | 1.1352 mL |